Get 20% lifetime commission for referring investors to digrin.com
here.
GUFIC BIOSCIENCES (GUFICBIO.NS) Financials
GUFICBIO.NS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 9.7 billion | 5.8 billion |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 8.6 billion | 5.1 billion |
GUFICBIO.NS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 82.8 million | ? |
| 2023-09-30 | 85.9 million | ? |
| 2023-06-30 | 84.7 million | ? |
| 2023-03-31 | 118.4 million | ? |
GUFICBIO.NS Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | 222.6 million |
| 2023-09-30 | 232.1 million |
| 2023-06-30 | 206.2 million |
| 2023-03-31 | 181.1 million |
GUFICBIO.NS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 163.2 million | - | 195.8 million |
| 2023-06-30 | 286.0 million | - | - |
| 2023-03-31 | 466.9 million | 2.1 billion | 227.9 million |
GUFICBIO.NS Shares Outstanding
GUFICBIO.NS Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | - | - | - | - |
| 2023-06-30 | - | - | 233.7 million | - |
| 2023-03-31 | 1.9 billion | 51.9 million | 304.4 million | 59.6 million |
GUFICBIO.NS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 2.0 billion | 1.3 billion |
| 2023-09-30 | 2.1 billion | 1.1 billion |
| 2023-06-30 | 2.0 billion | 968.4 million |
| 2023-03-31 | 1.7 billion | 825.6 million |
GUFICBIO.NS
Price: ₹344.75
52 week price:
5-year range yield:
Forward Dividend Yield: 0.03%
Payout Ratio: 1.16%
Payout Ratio Range:
Dividend Per Share: 0.10 INR
Earnings Per Share: 8.62 INR
P/E Ratio: 38.99
Exchange: NSI
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 31.8 billion
Average Dividend Frequency: 1
Years Paying Dividends: 16